AstraZeneca loses Seroquel appeal

10-05-2013

The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.


AstraZeneca, Seroquel, dosage, drug formulation, Hexal

LSIPR